The anemia of inflammation

Journal of Clinical Rheumatology

Volumn 18, Issue 8, 2012, Pages 437-442

  Stein, Brady Lee ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; BONE MORPHOGENETIC PROTEIN 6; ERYTHROPOIETIN; FERRITIN; FERROPORTIN; HEPCIDIN; INFLIXIMAB; INTERLEUKIN 6; IRON; TOCILIZUMAB; VITAMIN D;

ANEMIA; ANEMIA OF INFLAMMATION; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CYTOKINE PRODUCTION; ERYTHROCYTE LIFESPAN; ERYTHROPOIESIS; HEMOLYSIS; HORMONE BLOOD LEVEL; HUMAN; INFLAMMATION; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON METABOLISM; IRON TRANSPORT; MICROCYTOSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; RHEUMATOID ARTHRITIS;

ANEMIA; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIMICROBIAL CATIONIC PEPTIDES; ARTHRITIS, RHEUMATOID; ERYTHROPOIESIS; ERYTHROPOIETIN; HUMANS; INFLAMMATION; INTERLEUKIN-6; IRON; VITAMIN D; VITAMINS;

EID: 84871790563     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0b013e318278f553     Document Type: Article

References (33)

1. Wilson A, Yu HT, Goodnough LT, et al. Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature. Am J Med. 2004;116(suppl 7A):50SY7S.
2. Ganz T. Anemia of Chronic Disease. In: Lichtman MA, Kipps TJ, Seligsohn U, et al, eds. Williams Hematology. 8th ed. New York, NY: McGraw-Hill; 2010.
3. Cartwright GE. The anemia of chronic disorders. Semin Hematol. 1966;3:351-375.
4. Wilson A, Yu HT, Goodnough LT, et al. Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature. Am J Med. 2004;116(suppl 7A):50S-7S.
5. Ganz T. Anemia of Chronic Disease. In: Lichtman MA, Kipps TJ, Seligsohn U, et al, eds. Williams Hematology. 8th ed. New York, NY: McGraw-Hill; 2010.
6. Cartwright GE. The anemia of chronic disorders. Semin Hematol. 1966;3:351-375.
7. JCR: Journal of Clinical Rheumatology & Volume 18, Number 8, December 2012 Anemia and inflammation 2012 Lippincott Williams & Wilkins www.jclinrheum.com 441 Copyright 2012 Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
8. Cash JM, Sears DA. The anemia of chronic disease: spectrum of associated diseases in a series of unselected hospitalized patients. Am J Med. 1989;87:638-644. (Pubitemid 20006501)
9. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352:1011-1023.
10. Gardner LB and Benz EJ. Anemia of Chronic Disease. In: Hoffman R, Benz EJ Jr, Shattil SJ, eds. Hematology: Basic Principles and Practices pp. (469-474). 5th ed Philadelphia, PA: Churchill Livingstone Elsevier; 2008.
11. Roy CN. Anemia of inflammation. Hematol Am Soc Hematol Educ Program. 2010;2010:276-280.
12. Roodman GD, Horadam VW, Wright TL. Inhibition of erythroid colony formation by autologous bone marrow adherent cells from patients with the anemia of chronic disease. Blood. 1983;62:406-412. (Pubitemid 13036092)
13. Adamson JW. The anemia of inflammation/malignancy: mechanisms and management. Hematol Am Soc Hematol Educ Program. 2008:159-165.
14. Faquin WC, Schneider TJ, Goldberg MA. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood. 1992;79:1987-1994.
15. Miller CB, Jones RJ, Piantadosi S, et al. Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med. 1990;322:1689-1692. (Pubitemid 20231525)
16. Ganz T. Hepcidin and iron regulation, 10 years later. Blood. 2011;117:4425-4433.
17. Ganz T, Nemeth E. Hepcidin and disorders of iron metabolism. Annu Rev Med. 2011;62:347-360.
18. Ferrucci L, Semba RD, Guralnik JM, et al. Proinflammatory state, hepcidin, and anemia in older persons. Blood. 2010;115:3810-3816.
19. Skikne BS, Punnonen K, Caldron PH, et al. Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index. Am J Hematol. 2011;86:923-927.
20. van Santen S, van Dongen-Lases EC, de Vegt F, et al. Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia. Arthritis Rheum.2011;63:3672-3680.
21. Nissenson AR, Goodnough LT, Dubois RW. Anemia: not just an innocent bystander? Arch Intern Med. 2003;163:1400-1404. (Pubitemid 36758911)
22. Genovese MC, McKay JD, Nasonov EL, et al. Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study. Arthritis Rheum. 2008;58:2968-2980.
23. Smolen JS, Beaulieu A, Rubbert-Roth A, et al. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Lancet. 2008;371:987-997. (Pubitemid 351392039)
24. Doyle MK, Rahman MU, Han C, et al. Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials. Semin Arthritis Rheum. 2009;39:123-131.
25. Song SN, Tomosugi N, Kawabata H, et al. Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease. Blood. 2010;116:3627-3634.
26. Goodnough LT, Nemeth E, Ganz T. Detection, evaluation, and management of iron-restricted erythropoiesis. Blood. 2010;116:4754-4761.
27. Kaltwasser JP, Kessler U, Gottschalk R, et al. Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis. J Rheumatol. 2001;28:2430-2436. (Pubitemid 33031972)
28. Perlstein TS, Pande R, Berliner N, et al. Prevalence of 25-hydroxyvitamin D deficiency in subgroups of elderly persons with anemia: association with anemia of inflammation. Blood. 2011;117:2800-2806.
29. Bacchetta JZ, Lisse TS. Vitamin D as a new regulator of iron metabolism: vitamin D suppresses hepcidin in vitro and in vivo. J Am Soc Nephrol. 2011;22:474A.
30. Lac PT, Choi K, Liu IA, et al. The effects of changing vitamin D levels on anemia in chronic kidney disease patients: a retrospective cohort review. Clin Nephrol. 2010;74:25-32.
31. Kumar VA, Kujubu DA, Sim JJ, et al. Vitamin D supplementation and recombinant human erythropoietin utilization in vitamin DYdeficient hemodialysis patients. J Nephrol. 2011;24:98-105.
32. Sun CC, Vaja V, Babitt JL, et al. Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation. Am J Hematol. 2012;87:392-400.
33. Bloxham E, Vagadia V, Scott K, et al. Anaemia in rheumatoid arthritis: can we afford to ignore it? Postgrad Med J. 2011;87:596-600.